FDA Drug Safety Communication: Safety Review Update of Benicar (olmesartan) and cardiovascular events

This safety review update is in follow-up to the FDA Drug Safety Communication:Ongoing Safety Review of Benicar (olmesartan) and cardiovascular events on 6/11/2010.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Source Type: news